Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2010: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Research Abstract |
In many cancer patients, immune system is subverted by immunosuppressive cells as well as tumor-derived factors, which contributes to tumor progression. Tumor-associated macrophages with immunosuppressive, M2-like phenotype support the tumor growth by several mechanisms. Here, we show that double-stranded RNA(dsRNA) adjuvant induces growth retardation of 3LL tumor by converting tumor-supporting macrophages to tumoricidal effectors through the activation of TLR3-TICAM-1 signaling pathway
|